IART240920C45000
- 2.10
- 0.000.00%
Integra Lifesciences Newsroom
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued?
Integra LifeSciences Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $35
Morgan Stanley Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $25
A Quick Look at Today's Ratings for Integra Lifesciences(IART.US), With a Forecast Between $22 to $35
Integra Lifesciences (IART) Receives a Sell From Morgan Stanley
Truist Financial Reaffirms Their Hold Rating on Integra Lifesciences (IART)
Express News | Integra Lifesciences Shares Are Trading Lower After Citigroup and BTIG Both Downgraded the Stock From Neutral to Sell. The Company Recently Lowered Its FY24 Guidance
Express News | Integra Lifesciences : Morgan Stanley Cuts Target Price to $25.00 From $27.00
Express News | BTIG Downgrades Integra Lifesciences to Sell, Announces $22 Price Target
Integra Lifesciences Analyst Ratings
Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating
Integra Lifesciences Downgraded to Sell on Revised Guidance and Compliance Concerns
Express News | Integra Lifesciences Holdings Corp : Btig Cuts to Sell From Neutral
Express News | Integra Lifesciences Holdings Corp : Jefferies Cuts Target Price to $35 From $48
Buy Rating Affirmed for Integra Lifesciences Amidst Growth and Recovery Potential
Integra Lifesciences | 10-Q: Q2 2024 Earnings Report
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session